Symptomatic Study Investigating Degarelix in Patients Suffering From Prostate Cancer
Clinical trial NCT00831233 · TERMINATED
Trial details
- NCT number
- NCT00831233
- Sponsor
- Ferring Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-01
- Primary completion
- 2010-06-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.